Rho-Kinase and RGS-Containing RhoGEFs as Molecular Targets for the Treatment of Erectile Dysfunction

E-ISSN： 1873-4286|11|31|4029-4040

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.31, 2005-12, pp. : 4029-4040

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction

By Cellek Selim Rees Rowland W Kalsi Jas

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1563-1573

Informa Healthcare

Access to resources Recommend Favorite

Rho-Kinase as a Drug Target for the Treatment of Airway Hyperresponsiveness in Asthma

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-03 ,pp. : 339-348

Bentham Science Publishers

Access to resources Recommend Favorite

Rho-kinase inhibitors offer a new approach in the treatment of glaucoma

By Challa Pratap Arnold John J

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 81-95

Informa Healthcare

Access to resources Recommend Favorite

The Role of Rho Kinase Inhibitors in Corneal Endothelial Dysfunction

Current Pharmaceutical Design, Vol. 23, Iss. 4, 2017-03 ,pp. : 660-666

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Molecular Targets for Treatment of Erectile Dysfunction: Vascular and Regenerative Therapies on the Horizon

Current Drug Targets, Vol. 16, Iss. 5, 2015-05 ,pp. : 427-441

Bentham Science Publishers

Access to resources Recommend Favorite